These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 1453906
1. Carbamylation and glycosylation of haemoglobin in vitro: effects of cyanate and glucose. Ationu A. Med Lab Sci; 1992 Mar; 49(1):34-7. PubMed ID: 1453906 [Abstract] [Full Text] [Related]
4. The effects of cyanate in vitro on red blood cell metabolism and function in sickle cell anemia. De Furia FG, Miller DR, Cerami A, Manning JM. J Clin Invest; 1972 Mar; 51(3):566-74. PubMed ID: 5011101 [Abstract] [Full Text] [Related]
7. Factors determining hemoglobin carbamylation in renal failure. Stim J, Shaykh M, Anwar F, Ansari A, Arruda JA, Dunea G. Kidney Int; 1995 Nov; 48(5):1605-10. PubMed ID: 8544421 [Abstract] [Full Text] [Related]
8. Interference of carbamylated and acetylated hemoglobins in assays of glycohemoglobin by HPLC, electrophoresis, affinity chromatography, and enzyme immunoassay. Weykamp CW, Penders TJ, Siebelder CW, Muskiet FA, van der Slik W. Clin Chem; 1993 Jan; 39(1):138-42. PubMed ID: 8419039 [Abstract] [Full Text] [Related]
9. Reactivity of cyanate with valine-1 (alpha) of hemoglobin. A probe of conformational change and anion binding. Nigen AM, Bass BD, Manning JM. J Biol Chem; 1976 Dec 10; 251(23):7638-43. PubMed ID: 1002704 [Abstract] [Full Text] [Related]
10. Kinetics of the cyanate-hemoglobin reaction in whole blood. Uvelli DA, Fry DL, Finch CA, Babb AL. J Lab Clin Med; 1977 May 10; 89(5):978-86. PubMed ID: 16070 [Abstract] [Full Text] [Related]
12. Carbamylation is a competitor of glycation for protein modification in vivo. Nicolas C, Jaisson S, Gorisse L, Tessier FJ, Niquet-Léridon C, Jacolot P, Pietrement C, Gillery P. Diabetes Metab; 2018 Mar 10; 44(2):160-167. PubMed ID: 28690125 [Abstract] [Full Text] [Related]
13. [Effect of in vitro carbamylation of erythrocytes on their rheological properties]. Colin F, Menez JF, Meskar A, Moan M, Le Roux AM, Vicariot M. Ann Biol Clin (Paris); 1987 Mar 10; 45(5):509-14. PubMed ID: 3425984 [Abstract] [Full Text] [Related]
15. Carbamylated haemoglobin in chronic renal failure. Smith WG, Holden M, Benton M, Brown CB. Clin Chim Acta; 1988 Dec 30; 178(3):297-303. PubMed ID: 3240603 [Abstract] [Full Text] [Related]
16. Clinical evaluation of measuring glycosylated hemoglobin levels for assessing the long-term blood glucose control in diabetics. Inada M, Oishi M, Nishikawa M, Kurata S, Imura H. Endocrinol Jpn; 1980 Aug 30; 27(4):411-5. PubMed ID: 6780328 [Abstract] [Full Text] [Related]
17. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation. Jensen M, Bunn HF, Halikas G, Kan YW, Nathan DG. J Clin Invest; 1973 Oct 30; 52(10):2542-7. PubMed ID: 4729047 [Abstract] [Full Text] [Related]
18. Quantification of loss of haemoglobin components from the circulating red blood cell in vivo. Willekens FL, Bosch FH, Roerdinkholder-Stoelwinder B, Groenen-Döpp YA, Werre JM. Eur J Haematol; 1997 Apr 30; 58(4):246-50. PubMed ID: 9186535 [Abstract] [Full Text] [Related]
19. Carbamylated hemoglobin: a potential marker for the adequacy of hemodialysis therapy in end-stage renal failure. Davenport A, Jones S, Goel S, Astley JP, Feest TG. Kidney Int; 1996 Oct 30; 50(4):1344-51. PubMed ID: 8887297 [Abstract] [Full Text] [Related]